Electrosurgical device with multiple monopolar electrode assembly

Information

  • Patent Grant
  • 10716612
  • Patent Number
    10,716,612
  • Date Filed
    Monday, December 12, 2016
    7 years ago
  • Date Issued
    Tuesday, July 21, 2020
    3 years ago
Abstract
An electrosurgical device having a handpiece including a controller and an electrode assembly extending from the handpiece is disclosed. The electrode assembly includes a monopolar blade and a monopolar electrode. The monopolar blade includes a conductive element partially coated with an insulator and electrically coupled to the controller to selectively deliver a monopolar radiofrequency (RF) cutting signal. The monopolar electrode is spaced apart and electrically isolated from the monopolar blade. The monopolar electrode includes an exposed major conductive surface electrically coupled to the controller to selectively deliver a monopolar RF hemostatic sealing signal with a dispersed fluid.
Description
BACKGROUND

This disclosure relates generally to the field of medical devices, systems and methods for use in surgical procedures. More specifically, this disclosure relates to electrosurgical devices, systems and methods that provide for cutting, coagulation, hemostasis, or sealing of bodily tissues including bone with an electrosurgical device.


Electrosurgery includes such techniques as cutting, coagulation, hemostasis, and/or sealing of tissues with the aid of electrodes energized with a suitable power source. Typical electrosurgical devices apply an electrical potential difference or signal between an active electrode and a return electrode on a patient's grounded body in a monopolar arrangement or between an active electrode and a return electrode on the device in bipolar arrangement to deliver electrical energy to the area where tissue is to be affected. The electrosurgical devices are typically held by the surgeon and connected to the power source, such as an electrosurgical unit having a power generator, via cabling.


Electrosurgical devices pass electrical energy through tissue between the electrodes to provide coagulation to control bleeding and hemostasis to seal tissue. Electrosurgical devices can also cut tissue through the use of plasma formed on the electrode. Tissue that contacts the plasma experiences a rapid vaporization of cellular fluid to produce a cutting effect. Typically, cutting and coagulation are often performed with electrodes in the monopolar arrangement while hemostasis is performed with electrodes in the bipolar arrangement.


Electrical signals can be applied to the electrodes either as a train of high frequency pulses or as a continuous signal typically in the radiofrequency (RF) range to perform the different techniques. The signals can include a variable set of parameters, such as power or voltage level, waveform parameters such as frequency, pulse duration, duty cycle, and other signal parameters that may be particularly apt or preferred for a given technique. For example, a surgeon could cut tissue using a first RF signal having a set of parameters to form plasma and control bleeding using a second RF signal having another set of parameters more preferred for coagulation. The surgeon could also use electrodes in a bipolar arrangement or a bipolar electrosurgical device for hemostatic sealing of the tissue that would employ additional RF signals having another set of parameters.


Historically, two distinct electrosurgical devices, one monopolar and the other bipolar, were used to perform different functions in surgery, such as tissue cutting and coagulating and tissue sealing. For example a surgeon would use a monopolar electrosurgical device to cut and coagulate tissue and use a bipolar electrosurgical device to seal the tissue. When different techniques or functions were performed during a surgical procedure, surgeons would switch between different devices. Switching between devices can lead to undesirable effects such as longer procedure times, longer response times to issues that unexpectedly develop during surgery, higher costs, and an increased likelihood of inaccuracy or imprecision.


To address these issues, some electrosurgical devices capable of performing multiple techniques such as cutting and coagulating tissue or cutting, coagulating, and sealing tissue, including fluid-assisted sealing of tissue, have been developed. Several such electrosurgical device are described, for example, in U.S. Pat. No. 8,632,533 to Greeley, et al., U.S. Patent Application Publication No. 2012/000465 to Conley, et al., U.S. Patent Application Publication No. 2011/0178515 to Bloom et al., each assigned to the assignee of the present disclosure and incorporated by reference herein in their entireties to the extent they are not inconsistent with the present disclosure.


Several devices that have been developed include a hand piece having two electrodes. These devices can be configured as bipolar electrodes connected to a source of bipolar power to operate in a bipolar mode, for example to seal tissue. To operate the same two-electrode device in a monopolar mode, for example to cut tissue, one of the two electrodes may be selectively deactivated and the other of the two electrodes coupled to a source of monopolar power. In this manner, the multiple function device may provide treatment to tissue utilizing one or both electrodes depending upon the desired tissue treatment.


Despite having the ability to perform different functions with a single device, when monopolar function is desired only one of the two electrodes of the device are utilized and the deactivated second electrode may obstruct the view of the surgeon during the monopolar operation. Furthermore, the deactivated electrode may unnecessarily prevent the monopolar electrode from entering smaller spaces or tissue areas that could otherwise be accessed if the unused electrode was not exposed. Further still, devices may not perform similarly to independent bipolar and monopolar devices.


SUMMARY

This summary is provided to introduce a selection of concepts in a simplified form that are further described below in the Detailed Description.


In one aspect, the disclosure relates to an electrosurgical device having a handpiece including a controller and an electrode assembly extending from the handpiece. The electrode assembly includes a monopolar blade and a monopolar electrode. The monopolar blade includes a conductive element partially coated with an insulator and electrically coupled to the controller to selectively deliver a monopolar radiofrequency (RF) cutting signal. The monopolar electrode is spaced apart and electrically isolated from the monopolar blade. The monopolar electrode includes an exposed major conductive surface electrically coupled to the controller to selectively deliver a monopolar RF hemostatic sealing signal with a dispersed fluid. In one example, the controller includes a pushbutton to electrically couple the monopolar blade to the monopolar electrode before electrically coupling the monopolar RF hemostatic sealing signal to the monopolar electrode.


In one aspect, the disclosure relates to an electrosurgical device having a handpiece and an electrode assembly extending from the handpiece. The electrosurgical device is configured to be used with an electrosurgical generator unit and a return electrode. The electrode assembly includes an electrically insulative intermediate component coupled to, and electrically isolating, a monopolar blade and a monopolar electrode. The monopolar blade and monopolar electrode can be configured as active electrodes in a monopolar arrangement. The electrosurgical device is configured to deliver a monopolar RF signal for cutting and a monopolar RF signal for coagulating to the monopolar blade. The electrode assembly is also configured to disperse a fluid, such as saline, and deliver a monopolar RF signal for hemostatic sealing with the monopolar electrode.


In one aspect, the disclosure relates to an electrosurgical device having a handpiece including a controller. A shaft extends from the handpiece. The shaft includes a hypotube configured to deliver a fluid and includes a conductive element. An electrode assembly extends from the shaft. The electrode assembly includes a monopolar blade and a monopolar electrode. The monopolar blade includes a conductive element partially coated with an insulator and electrically coupled to the controller to selectively deliver a monopolar radiofrequency (RF) cutting signal. The monopolar electrode is spaced apart and electrically isolated from the monopolar blade. The monopolar electrode includes an exposed major conductive surface electrically coupled to the controller via the conductive element to selectively deliver a monopolar RF hemostatic sealing signal with a dispersed fluid via the hypotube. In one example, the shaft has a variable length, and the hypotube includes an extendable and yieldably collapsible coil segment.


The monopolar blade in one example desiccates tissue with the monopolar RF signal for cutting via plasma. The creation of plasma to cut tissue includes producing a very high current density in the monopolar blade. In the monopolar arrangement, the active electrode is generally much smaller than the return electrode to allow the plasma to form at the active electrode and not at the return electrode. In order to further increase the current density, reduce the power used to cut tissue in the monopolar arrangement, or a combination of both, the monopolar blade may include a conductive element such as stainless steel partially coated with an electrically insulative material such as glass or ceramic to leave a small exposed area of the conductive element to create the plasma on the monopolar blade. The glass or ceramic insulator also serves as a thermal shield, which reduces the heat on the outer surface of the monopolar blade in the locations of conductive element covered with the insulator, to protect areas of tissue from thermal damage.


The conductive element and insulative coating cooperate to form a sturdy, substantially sized cutting blade having only a fraction of the conductive surface area of a similarly sized metal blade to increase the current density and reduce the size of a thermal damage zone. Thus, the monopolar conductive element serves to harness and focus the monopolar energy allowing it to create plasma for precise dissection and coagulation with reduced power, a higher current density at the conductive element, or a combination of reduced power and higher current density than available in a similarly sized metal blade.


The monopolar electrode is configured from an uncoated metal to be substantially larger in conductive surface area than the monopolar blade. The monopolar electrode is configured to avoid creating plasma, and to produce a relatively low current density, with the monopolar RF signal for hemostatic sealing. Furthermore, the monopolar electrode of the examples is configured with a fluid port to disperse a fluid for hemostatic sealing. In one example, an electrically conductive hypotube is electrically coupled to the monopolar electrode and fluidly coupled to the fluid port to deliver the monopolar RF signal for hemostatic sealing to the monopolar electrode and to disperse an energized conductive fluid. The intermediate component electrically insulates the monopolar electrode and hypotube from the monopolar blade.


The electrode assembly can be readily fabricated on a large scale. In one example, the hypotube is welded to the monopolar electrode, which are overmolded with an electrically insulative plastic, such as polytetraflouroethylene (PTFE) based material or others, to form the intermediate component. The monopolar blade is attached to the intermediate component. The electrode assembly can be electrically coupled to a controller, fluidly coupled to tubing, and welded to a shaft of a handpiece to form the electrosurgical device.


The monopolar blade can be specifically configured for cutting or desiccating tissue and operated with cutting and coagulating RF energy, which is performed with a relatively high impedance electrode and a high current density to form plasma. The monopolar electrode can be specifically configured to perform the techniques of hemostatic tissue sealing, which is performed with a relatively lower impedance electrode and a lower current density and a dispersed fluid. Thus, a clinician can perform multiple electrosurgical functions without having to change devices, or from monopolar to bipolar mode or vice versa.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a front view illustrating an embodiment of a system according to the present disclosure including an example electrosurgical unit in combination with a fluid source and example handheld electrosurgical device.



FIG. 2 is a perspective view illustrating an example of the electrosurgical device of FIG. 1 including a multiple monopolar electrode assembly.



FIG. 3 is a close-up perspective view illustrating the electrosurgical device of FIG. 2 illustrating an example multiple monopolar electrode assembly.



FIG. 4 is a perspective view illustrating the multiple monopolar electrode assembly of FIG. 3.



FIG. 5 is an exploded view illustrating the multiple monopolar electrode assembly of FIG. 3.



FIG. 6 is a top view illustrating a cross section of the multiple monopolar electrode assembly of FIG. 3.



FIG. 7 is a close-up view illustrating an example of a hypotube for electrosurgical device of FIG. 2.



FIG. 8 is a side view illustrating an example of the hypotube of FIG. 7.





DETAILED DESCRIPTION

Throughout the description, like reference numerals and letters indicate corresponding structure throughout the several views. Also, any particular features(s) of a particular exemplary embodiment may be equally applied to any other exemplary embodiment(s) of this specification as suitable. That is, features between the various exemplary embodiments described herein are interchangeable as suitable and may not be exclusive. From the specification, it should be clear that the terms “distal” and “proximal” are made in reference to a user of the device.



FIG. 1 illustrates a front view of one example of a system 60 that includes an electrosurgical unit 10 in combination with an example handheld electrosurgical device 30. The device 30, in one example, can be configurable for use in cutting and sealing including electrocautery and coagulation in a first monopolar mode using a first monopolar electrode. In another example, device 30 can be configured to provide for hemostatic sealing of tissue including bone in a second monopolar mode using at least a second monopolar electrode in combination with a fluid source 20, or for other electrical surgical procedures.


The system 60 can be carried on a movable cart 2 having a support member 4 comprising a hollow cylindrical post which includes a platform 6 comprising a pedestal table to provide a flat, stable surface for location of the electrosurgical unit 10. Cart 2 can include a pole 8 having a height that can be adjusted by sliding the pole 8 up and down. Fluid source 20 can be supported at the top of pole 8.


Fluid source 20 may comprise a bag of fluid from which fluid 12 may flow through a drip chamber 14, to delivery tubing 16 and to handheld electrosurgical device 30. In one example, the fluid 12 includes saline and can include physiologic saline such as sodium chloride (NaCl) 0.9% weight/volume solution. Saline is an electrically conductive fluid, and other suitable electrically conductive fluids can be used. In other examples, the fluid may include a nonconductive fluid, such as deionized water, which may still provide advantages over using no fluid and may support cooling of portions of electrosurgical device 30 and tissue or reducing the occurrence of tissue sticking to the electrosurgical device 30.


The fluid delivery tubing 16 in the example passes through pump 22 to convey fluid to the electrosurgical device 30 and control fluid flow. Pump 22 in one example is a peristaltic pump such as a rotary peristaltic pump or a linear peristaltic pump. A peristaltic pump can convey the fluid through the delivery tubing 16 by way of intermittent forces placed on the external surface of the delivery tubing. Peristaltic pumps are often applied during use of the electrosurgical device 30 because the mechanical elements of the pump places forces on the external surface of the delivery tubing and do not come into direct contact with the fluid, which can reduce the likelihood of fluid contamination. Other examples of system 60 might not include a pump, and fluid can be is provided to the electrosurgical device 30 via gravity.


The example electrosurgical unit 10 can provide at least one or more monopolar RF power outputs to a specified electrosurgical instrument such as electrosurgical device 30. In one example, the electrosurgical unit 10 can be used for delivery of RF energy to instruments indicated for cutting and coagulation of soft tissue and for delivery of RF energy concurrent with fluid to instruments indicated for hemostatic sealing and coagulation of soft tissue and bone. In one example, the electrosurgical unit 10 can be capable of simultaneously or separately powering specified monopolar electrodes.


During monopolar operation of electrosurgical device 30, an active electrode is provided with electrosurgical device 30 while an indifferent, or neutral, electrode is provided in the form of a ground pad dispersive electrode located on a patient. For example, the ground pad dispersive electrode is typically on the back, buttocks, upper leg, or other suitable anatomical location during surgery. In such a configuration, the ground pad dispersive electrode is often referred to as a patient return electrode. An electrical circuit of RF energy is formed between the active electrode and the ground pad dispersive electrode through the patient. (In comparison, bipolar electrosurgical devices include a second electrode, often referred to as the return electrode providing a second electrical pole. The ground pad dispersive electrode is not used. An electrical circuit of RF energy is created between the first and second poles of a bipolar device. The current no longer flows through the patient's body to the ground pad dispersive electrode, but rather through a localized portion of tissue between the poles of the bipolar device.)


The electrosurgical device 30 in the example is connected to electrosurgical unit 10 via cable 24. Cable 24 includes plugs 34 that connect with receptacles 36 on the electrosurgical unit 10. In one example, a receptacle can correspond with an active electrode receptacle and one or more receptacles can correspond with controls on the electrosurgical device 30. Still further, a receptacle can correspond with a second active electrode receptacle. An additional cable may connect a ground pad electrode to a ground pad receptacle of the electrosurgical unit 10. In some examples, delivery tubing 16 and cable 24 are combined to form a single cable 26.


The features of electrosurgical unit 10 described are for illustration, and the electrosurgical units suitable for use with device 30 may include some, all, or other features than those described below. In one example, the electrosurgical unit 10 is capable of operating in at least monopolar mode as well as multiple functions within the monopolar mode such as a monopolar cutting function, a monopolar coagulation function, and monopolar hemostasis or tissue sealing function. In the monopolar cutting function, monopolar RF energy is provided to the device 30 at a first power level and/or a first waveform (collectively first, or cutting RF energy setting). For example, cutting RF energy for a cut function may be provided at a relatively low voltage and a continuous current (100% on, or 100% duty cycle). Nominal impedance can range between 300 to 1000 ohms for the cutting function. At a power setting of 90 Watts for cutting, voltage can range from approximately 164 to 300 volts root mean square (RMS). In the monopolar coagulation function, monopolar RF is energy is provided to the electrode at a second power level and/or second waveform (collectively second, or coagulating RF energy setting) that is different than at least one of the first power level or the first waveform. For example, coagulating RF energy for a coagulation function may be provided at a relatively higher voltage than the cut voltage and with a pulsed current, such as 1% to 6% on and 99% to 94% off, respectively (or 1% to 6% duty cycle). Other duty cycles are contemplated. The electrosurgical unit 10 may provide monopolar RF energy at a third power level and/or third waveform (collectively third, or hemostatic sealing RF energy setting) along with fluid for a (generally low voltage) hemostasis or tissue sealing function that may be the same as or different than the cutting and coagulating RF settings provided to the device 30 for the cut function or the coagulation function. In one example, hemostatic sealing energy can be provided with a continuous current (100% duty cycle). Nominal impedance can range between 100 to 400 ohms for the hemostatic sealing function. At a power setting of 90 Watts for hemostatic sealing, voltage can range from approximately 95 to 200 volts RMS.


In one example, the electrosurgical unit 10 provides RF energy to the active electrode as a signal having a frequency in the range of 100 KHz to 10 MHz. Typically this energy is applied in the form of bursts of pulses. Each burst typically has a duration in the range of 10 microseconds to 1 millisecond. The individual pulses in each burst typically each have a duration of 0.1 to 10 microseconds with an interval between pulses of 0.1 to 10 microseconds. The actual pulses are often sinusoidal or square waves and bi-phasic, that is alternating positive and negative amplitudes. Several other features are described in U.S. Pat. No. 8,323,276, to Palanker et al., and incorporated by reference herein in its entirety to the extent it is not inconsistent with the present disclosure.


The electrical surgical unit 10 includes a power switch to turn the unit on and off and an RF power setting display to display the RF power supplied to the electrosurgical device 30. The power setting display can display the RF power setting numerically in a selected unit such as watts.


The example electrosurgical unit 10 includes an RF power selector comprising RF power setting switches that are used to select or adjust the RF power setting. A user can push one power setting switch to increase the RF power setting and push the other power setting switch to decrease the RF power setting. In one example, power setting switches are membrane switches, soft keys, or as part of a touchscreen. In another example, the electrosurgical unit may include more than one power selectors such as a power selector corresponding with each of the different monopolar settings used in the different functions.


The example electrosurgical unit 10 can also include fluid flow rate setting display and flow rate setting selector. The display can include indicator lights, and the flow rate selector can include switches. Pushing one of the flow rate switches selects a fluid flow rate, which is than indicated in display.


While not being bound to a particular theory, the relationship between the variables of fluid flow rate Q (such as in units of cubic centimeters per minute (cc/min)) and RF power setting Ps (such as in units of watts) can be configured to inhibit undesired effects such as tissue desiccation, electrode sticking, smoke production, char formation, and other effects while not providing a fluid flow rate Q at a corresponding RF power setting Ps not so great as to disperse too much electricity and or overly cool the tissue at the electrode/tissue interface. Electrosurgical unit 10 is configured to increase the fluid flow rate Q generally linearly with an increasing RF power setting Ps for each of the three fluid flow rate settings of low, medium, and high.


Electrosurgical unit 10 can be configured to include control of the pump 22. In this example, the speed of the pump 22, and the fluid throughput, can be predetermined based on input variables such as the RF power setting and the fluid flow rate setting. In one example, the pump 22 can be integrated with the electrosurgical unit 10.


Several electrosurgical units, or generators, are described, for example, in U.S. patent application Ser. No. 14/927,999 to Smith, et al., titled RF Output Stage Switching Mechanism, filed Oct. 30, 2015; U.S. patent application Ser. No. 14/928,020 to Hubelbank, et al., titled Finger Switch Circuitry to Reduce Leakage Current, filed Oct. 30, 2015; U.S. patent application Ser. No. 14/927,969 to Smith, et al., titled Power Monitoring Circuitry and Method for Reducing Leakage Current in RF Generators, filed Oct. 30, 2015; and U.S. Patent Application Publication No. 2006/0149225 to McClurken, each assigned to the assignee of the present disclosure and incorporated by reference herein in their entireties to the extent they are not inconsistent with the present disclosure.


While electrosurgical device 30 is described with reference to electrosurgical unit 10 and other elements of system 60, it should understood the description of the combination is for the purposes of illustrating system 60. It may be possible to use the electrosurgical device 30 in other systems or the electrosurgical unit 10 may be used with other electrosurgical devices.



FIG. 2 illustrates one example of an electrosurgical device 70, which can provide an example of electrosurgical device 30, having a multiple monopolar electrode assembly 100. In the example, the electrosurgical device 70 multiple monopolar electrode assembly 100 includes a first monopolar electrode configured in the example as a monopolar blade 102 operable to provide one or more functions in a monopolar mode, such as cutting and coagulation, and at least one or more monopolar electrodes 104 operable to provide additional functions in a monopolar mode, including hemostatic sealing of bone and tissue using a dispersed fluid, such as fluid 12.


Electrosurgical device 70 extending along longitudinal axis A includes a handpiece 80. Handpiece 80 includes a handle 82 having a finger grip portion 84 with ridges shown on the lower surface or bottom B of the device 70 and intended to be held in the surgeon's hand. The handpiece 80 includes a proximal end 86 for balance and, in the example, includes an electrical connector for electrically coupling cable 24 to the device 70.


Handpiece 80 may be configured to enable a user of electrosurgical device 70 to hold and manipulate device 70 between the thumb and index finger like a writing instrument or an electrosurgical pen. Handpiece 80 may comprise a sterilizable, rigid, electrically insulative material, such as a synthetic polymer (e.g., polycarbonate, acrylonitrile-butadiene-styrene). The handle 82 can include an upper surface, or top T, opposite bottom B. A controller 88, such as a set of one or more switches coupled to circuitry such as on a printed circuit board, in the example is disposed on top T and configured to be operated by the user's thumb or index finger to activate the electrode assembly 100.


The electrosurgical device 70 can include a probe assembly 90 extending distally from the handpiece 80. The probe assembly 90 in the example includes a body portion 92 attached to a shaft 94. The shaft 94, or other portions of electrosurgical device 70 may include one or more elements forming a subassembly to be generally one or more of rigid, bendable, fixed-length, variable-length (including telescoping or having an axially-extendable or axially-retractable length) or other configuration. An example of an electrosurgical device having a telescoping shaft is described in U.S. Patent Application Publication No. 2016/0120592 to Sylvester, et al. assigned to the assignee of the present disclosure and incorporated by reference herein in its entirety to the extent it is not inconsistent with the present disclosure. The shaft 94 carries one or more electrical conductors to a distal end 96 including the electrode assembly 100. The electrode assembly 100 includes a distal tip 98. Electrical pathways within the handpiece 80 and probe assembly 90 can be formed as conductive arms, wires, traces, other conductive elements, and other electrical pathways formed from electrically conductive material such as metal and may comprise stainless steel, titanium, gold, silver, platinum or any other suitable material. In the example, the shaft 94 includes a fluid lumen extending into the handpiece 80 for fluidly coupling to delivery tubing 16 in cable 26. The fluid lumen includes an outlet port 106 disposed on the electrode assembly 100 for selectively dispersing fluid 12.


In one example, the controller 88 includes one or more pushbuttons on the handle 82 in combination with circuitry such as a PCB within the electrosurgical device 70 to provide binary activation (on/off) control for each function. For example, one button 88a may be pressed to activate the monopolar blade 102 in a cut function, another button 88b may be pressed to activate the monopolar blade 102 in a coagulation function, and still another button 88c may be pressed to activate the monopolar electrode 104 and disperse fluid from port 106 in a sealing function and disperse fluid 12. Alternate configurations of the controller 88 and its activation are contemplated. In one example, the monopolar electrode 104 is not active (and fluid is not dispersed from fluid port 106) when cutting and coagulating RF energy is provided to the monopolar blade 102, but the monopolar blade 102 is active when hemostatic sealing RF energy is provided to the monopolar electrode 104.


The monopolar electrode 104 can be connected to the monopolar blade 102 when the activation button for one or more modes is depressed. Because the monopolar electrode 104 can be in contact with the tissue while the monopolar blade 102 is active, the monopolar electrode 104 in one example is configured to be isolated from the full output voltage of the electrical surgical unit 10. Also, the controller 88 can be configured to make two separate contacts such as a contact with high voltage isolation for the monopolar electrode 104, and on a contact with low voltage isolation for the controller 88.


Accordingly, the controller 88 can provide a controlled make and break order of electrical connections with one or more pushbuttons 88a, 88b, and 88c. A traditional micro switch may not provide isolation and using dual micro switches even if one has adequate isolation may be applied in an incorrect order. To over come these challenges, the controller 88 can include a dome switch to provide isolation and order. The dome switch is used for the low voltage connection and is affixed to the circuit board of the controller 88 with an insulative tape, such as with a polyimide tape available under the trade designation Kapton from DuPont of Wilmington, Del. A hole is provided in the tape over the dome switch to expose metal underneath. A lever, such as a conductive spring, is positioned above the dome so that it strikes the exposed metal of the dome centered on the hole in the tape. This conductive lever is then electrically connected via the circuit board to the monopolar electrode 104. An insulated button top, such as one of push buttons 88a, 88b, 88c, is then placed over the lever and the dome in such a manner that when the user depresses the button top the lever is first pressed into contact with the top of the dome electrically connecting the monopolar electrode 104 to the monopolar blade 102. In one example, the low force of the lever provides no tactile feedback to the user upon the first press. When the button top is further depressed, however, the dome snaps and makes the second contact, providing tactile feedback, as well as connecting activation wires to deliver a monopolar signal to the electrode assembly 100. When the button top is released, this process is reversed and the electrosurgical unit 10 turns off before the electrode assembly 100 is disconnected.


While electrode assembly 100 is described with reference to electrosurgical surgical device 70 and other elements of system 60, it should understood the description of the combination is for the purposes of illustrating one example of an electrosurgical device 30 having electrode assembly 100. It may be possible to use the electrode assembly 100 in other electrosurgical devices or with other systems using other electrosurgical units.



FIG. 3 illustrates a close-up view of the distal end 96 of an electrosurgical device such as electrosurgical device 70. The electrode assembly 100 extends distally from shaft 94. Electrode assembly 100 includes monopolar blade 102 configured in the example as a relatively sharpened, high-impedance electrode blade for cutting and coagulating tissue with cutting and coagulating RF energy and monopolar electrode 104 configured as a relatively blunt, low-impedance conductor for hemostatic sealing of tissue and bone with a dispersed fluid using hemostatic sealing RF energy. The distal tip 96 also includes a fluid port 106 in fluid communication with tubing 16 for dispersing fluid 12. In the example, the monopolar electrode 104 includes the fluid port 106. The monopolar blade 102 is spaced-apart and electrically insulated from monopolar electrode 104 via an electrically insulative intermediate component 108.



FIG. 4 illustrates an example of the electrode assembly 100. The electrode assembly 100 can includes tail portion 110 configured to be attached to or disposed within the shaft 94, and an active portion 112 configured to extend distally from the shaft 94 and engage tissue.


Tail portion 110 in the example includes one or more electrical conductors, such as arms 114a, 144b, electrically coupled to the monopolar blade 102 and configured to be operably coupled to the controller 88 to provide cutting and coagulation RF energy to the monopolar blade 102 when activated. The tail portion 110 also includes hypotube 116 in fluid communication with fluid port 106 and tubing 16 for delivering fluid 12 to the active portion 112 and dispersing fluid 12 from the fluid port 106. In the example, hypotube 116 is electrically conductive or includes an electrically conductive portion such as a wire or trace that is operably coupled to electrode 104 and configured to be operably couple to the controller 88 to provide hemostatic sealing RF energy to the electrode 104 when activated. The hypotube 116 in the example is electrically isolated from the arms 114a, 114b. In one example, the arms 114a, 114b and hypotube 116 can be electrically coupled to the controller 88 using wires or other electrical leads in the shaft 94 or elsewhere in the electrosurgical device 70 via a spot weld or other connection so as to conduct electrical energy from the controller 88 to electrode assembly 100. Hypotube 116 and arms 114a, 114b are held spaced-apart from each other with the intermediate component 108.


The intermediate component 108 can be formed from an insulative material such as a high temperature micromolded polymer. Examples insulative materials can include polytetrafluoroethylene (PTFE), polycarbonate (PC), polyoxymethylene (POM or acetal), or polyether ether ketone (PEEK). Intermediate portion 108 includes first and second side surfaces 120a, 120b defining an edge 122 and an end 124. The example intermediate component 108 includes a rounded tip 126.



FIG. 5 illustrates an exploded view of the example electrode assembly 100 including the monopolar blade 102, monopolar electrode 104, hypotube 116, and intermediate portion 108. The intermediate component 108 includes an aperture 128 configured to receive the monopolar electrode 104. The intermediate portion 108 also includes a bore 130 having a proximal opening 132 on the end 124 and a distal opening 134 in the aperture 128 configured to receive the hypotube 116. Edge 122 of the intermediate component 108 includes a recessed groove 136 configured to received and hold the monopolar blade 102.



FIG. 6 illustrates a top view of a cross section of the example electrode assembly 100 of FIG. 4 taken along lines 6-6. The hypotube 116 is configured from a medical grade material suitable for saline, or other appropriate liquid, delivery. In one example, the hypotube 116 is also electrically conductive, or includes an electrically conductive portion (such as a sleeve, trace, or wire) and can be constructed from a stainless steel. The hypotube 116 includes an axially extending wall 140 forming a lumen 142 and includes an inlet 144 on a proximal end 146 and an outlet 148 on a distal end 150. The proximal end 146 is configured to extend proximally from the intermediate portion 108, as indicated in FIG. 3. The proximal end 146 of wall 140 can be coupled to a fluid lumen (not shown) within the handpiece 80 to fluidly couple the inlet 144 to the delivery tubing 16 for receiving the fluid 12 into the hypotube 116. Further, the proximal end 146 of wall 140 (or conductive sleeve) can be electrically coupled to the controller 88 to receive hemostatic sealing RF energy. The distal end 150 of the wall 140 (or conductive sleeve) can be electrically coupled to the monopolar electrode 104.



FIGS. 4 and 5 illustrate the active portion 112 of electrode assembly 100 includes a cutting blade 170 of the monopolar blade 102 and the monopolar electrode 104.


The monopolar electrode 104 can be formed from a conductive material such as stainless steel. In the example, the monopolar electrode 104 includes first and second major exposed conductive surfaces 160a, 160b, disposed on sides 120a, 120b, of the intermediate component 108. The major exposed conductive surfaces 160a, 160b are configured to engage tissue and bone and to deliver hemostatic sealing RF energy.



FIG. 6 illustrates major exposed conductive surfaces 160a, 160b are generally opposite each other on opposing discs 162a, 162b on either ends of an axially transverse conductive rod 164. In one example, the major exposed conductive surfaces 160a, 160b are generally flush with the side surfaces 120a, 120b of the intermediate component 108. In another example, the discs 162a, 162b extend longitudinally from the side surfaces 120a, 120b. Fluid port 106 is formed within discs 162a, 162b and rod 164, and extends as an opening from the first major conductive surface 160a to the second major conductive surface 160b in the illustrated examples. Rod 164 is received within aperture 128 of the intermediate portion 108 and includes an axially extending fluid passage 166.


The distal end 150 of the hypotube 116 is fluidly coupled to the rod 164 at the fluid passage 166. For example, the fluid passage 166 includes an inlet 168 in fluid communication with the lumen 142 of the hypotube 116, and the fluid passage includes an outlet 169 in fluid communication with the fluid port 106 such that the lumen 142 is in fluid communication with the fluid port 106. Fluid 12 from the delivery tubing 16 is passed into the handpiece 80 and into the hypotube 116 and from the hypotube into the rod 164 where it is dispersed from the fluid port 106 on the major conductive exposed surfaces 160a, 160b.


Additionally, monopolar electrode 104 is electrically coupled to the distal end 150 of the hypotube 116 to receive hemostatic sealing RF energy from the controller 88. The major conductive exposed surfaces 160a, 160b have a relatively large surface area to provide a relatively low impedance and low current density for the hemostatic sealing RF energy.



FIGS. 4 and 5 illustrate the cutting blade 170 of the monopolar blade 102 can be integrally formed with the arms 114a, 114b. Cutting blade 170 includes first and second major surfaces 172a, 172b forming a blade edge 174 around the perimeter 176 of the monopolar blade 102. The blade edge 174 can be sharp or tapered to mechanically dissect as well as electrosugically cut and coagulate tissue. As indicated in FIG. 5, the monopolar blade 102 can be horseshoe-shaped and includes an inner edge 178 that is connected to the recessed groove 136 on the edge 122 of the intermediate component 108.


In an example, the cutting blade 170 is formed from a conductive element 180 partially coated with an insulator 182 to expose a conductive cutting electrode 184 proximate the perimeter 176. By implementing the cutting electrode 184, the conductive element 180 and insulator 182 cooperate to form a sturdy, substantially sized cutting blade assembly having only a small fraction of the conductive surface area of a similarly sized fully exposed metal blade at the cutting electrode 184 to reduce the size of a thermal damage zone. Thus, the cutting blade 170 serves to harness and focus the monopolar energy allowing it to create plasma for precise dissection and coagulation with reduced power, a higher current density at the cutting electrode 184, or a combination of reduced power and higher current density than available in a similarly sized fully-exposed metal blade.


The conductive element 180 can be formed from a metal, such as stainless steel or titanium, and the insulator 182 can be formed of glass or ceramic. In one example, the conductive element 180 is formed from a ferritic and martensitic chromium alloy as in series 400 stainless steel, which also adheres well to a glass or ceramic coating. In one example, the conductive element 180 is series 420 stainless steel. The conductive element 180 can be machined, stamped, or etched out of a larger sheet of metal. The conductive element 180 can be honed to a sharp, tapered blade edge 174 on one or both sides 172a, 172b. In one example, the exposed conductive cutting electrode 184 includes a thickness of between about 1 micrometer and 100 micrometers. In some examples, the conductive element 180 can be coated with a glass or ceramic insulator 182, such as a glass enamel insulator 182, by dipping the conductive element 180 in liquid or molten glass and then annealing the glass prior to assembly. In one example, the insulator 182 has a thickness of between about half and three times the thickness of the exposed conductive cutting electrode 184. In one example, the width of the cutting blade 170 of monopolar blade 102, as measured in a direction from tail 114a to tail 114b, is more than twice the diameter of the major surfaces 160a, 160b of the monopolar blade 104.


In the illustrated example, the monopolar blade 102 includes a single conductive element 180 configured as the cutting blade 178. In some examples, however, the monopolar blade 102 can be formed of multiple pieces of conductive material and include separate electrodes that provide cut and coagulation functions, respectively, such as described in U.S. Pat. No. 8,414,572 to Davidson, et al., assigned to the assignee of the present disclosure and incorporated by reference herein in its entireties to the extent it is not inconsistent with the present disclosure.



FIG. 7 illustrates an example hypotube 190 configured for use as hypotube 116 to deliver fluid 12 and RF energy from the handpiece 80 to the monopolar electrode 104. Hypotube 190 includes an axially extending hollow tubing 192, a proximal conductive terminal 194 (such as at the proximal end 150), a distal conductive terminal 196 (such as at the distal end 146), and a conductive element 198 extending axially to electrically couple the proximal conductive terminal 194 to the distal conductive terminal 196. In the example, the proximal conductive element 194 and distal conductive terminal 196 each include a lumen to allow fluid 12 to flow such that, when coupled to the hypotube 190, the fluid port 106 is in fluid communication with tubing 16. Additionally, the conductive element 198 electrically couples the proximal conductive terminal 194 to the distal conductive terminal 196 such that the controller 88 is in electrical communication with monopolar electrode 104 to provide hemostatic sealing RF energy to the electrode 104 when activated.


In the example, the proximal conductive terminal 194, distal conductive terminal 196, and conductive element 198 are configured from a conductive stainless steel. The proximal conductive terminal 194 can be configured to form a hollow barb-like fitting on tubing 192 that can mate with tubing 16, such as commonly used flexible tubing 16, such as polyvinyl chloride (PVC) tubing 16, to supply fluid 12 to the electrosurgical device 70 or electrode assembly 100. The distal conductive terminal 196 can be configured as a cylindrical tube partially disposed within tube 192 having a distally extending end coupled to the rod 164. The proximal conductive terminal 194 is electrically coupleable to the controller and the distal conductive terminal 196 is electrically coupleable to the rod 164 at inlet 168.


The tube 192 can be constructed from a non-conductive material such as PVC, PEEK, or a thermoplastic elastomer (TPE). In one example, the TPE is a polyether block amide (PEBA) available under the trade designation PEBAX from Arkema of Colombes, France. The conductive element 198 can be formed in the wall or tube 192 or can extend within the lumen of the tube 192 from the proximal conductive element 194 to the distal conductive element 196, such as a wire within the lumen.



FIG. 8 illustrates an example hypotube 200, generally corresponding with hypotube 190 for use with, for example, an electrosurgical device 70 having a shaft 94 of selectably-variable length, such as axially extendable or axially retractable telescoping shaft such as an example of the telescoping device with saline irrigation line of U.S. Patent Publication No. 2016/0120592 described above. To translate axially, tube 192 and conductive element 198 flexible and are coiled to store the length for the hypotube 200 to extend and yieldably collapse within a selectively variable length shaft without slack, undue strain, or breakage in the fluid or electrical communication. Hypotube 200 includes a straight segment 202 including the distal conductive element 196, a tail segment 204 including the proximal conductive element 194, and an intermediate segment 206 wound into a coil. Conductive element 198 extends within the lumen of hypotube 200. In some examples, the straight segment 202 can be disposed within shaft 94 and coil of the intermediate segment 206 can be disposed within the body portion 92 or handpiece 80.


In some examples, the hypotube 200 can be formed from a stock piece of PEBA tubing. The length of the segments 202, 204, 206 can be selected by reference to dimensions of the electrosurgical device 70 including the length to fully extend and fully collapse. The time and temperature to shape and set the tubing can be selected based on various factors such as overall dimensions of the tubing, material used, stiffness of the coil desired, the propensity of the coil to lose shape after repeated extensions.


In one example of manufacturing electrode assembly 100, the monopolar blade 102, monopolar electrode 104, and hypotube 116 can be formed in separate processes and joined together. The hypotube 116 and monopolar electrode 104 can be welded together. The hypotube 116 joined with the monopolar electrode 104 can be overmolded with an electrically insulative material to form the intermediate component 108. The monopolar blade 102 can be attached to the intermediate component 108. The electrode assembly can be electrically coupled to a handpiece 80 and attached to the shaft 94. In one example, the electrode assembly can be attached to the shaft and handpiece of an electrosurgical device such as those sold under the trade designations PEAK PlasmaBlade 3.0, Peak PlasmaBlade 4.0, or similar products available from Medtronic Advanced Energy, LLC, of Minneapolis, Minn.


Although the present disclosure has been described with reference to preferred embodiments, workers skilled in the art will recognize that changes can be made in form and detail without departing from the spirit and scope of the present disclosure.

Claims
  • 1. An electrosurgical device suitable for coupling to an electrosurgical unit, the electrosurgical device comprising: a handpiece having a controller, the controller to receive a monopolar radiofrequency (RF) cutting signal and a monopolar RF hemostatic sealing signal from the electrosurgical unit, the controller to provide selective activation of the monopolar RF cutting signal and the monopolar RF hemostatic sealing signal in the electrosurgical device; andan electrode assembly extending from the handpiece, comprising: a monopolar blade having a conductive element partially coated with an insulator, the monopolar blade electrically coupled to the controller to receive the monopolar RF cutting signal from the controller; anda monopolar electrode spaced apart and electrically isolated from the monopolar blade, the monopolar electrode having an exposed major conductive surface, the monopolar electrode electrically coupled to the controller to receive the monopolar RF hemostatic sealing signal from the controller with a dispersed fluid.
  • 2. The electrosurgical device of claim 1 wherein the controller is configured to selectively deliver a monopolar RF coagulation signal to the monopolar blade.
  • 3. The electrosurgical device of claim 1 wherein the controller includes a first button to selectively deliver the RF cutting signal and a second button to selectively deliver the RF hemostatic sealing signal.
  • 4. The electrosurgical device of claim 1 where in the monopolar electrode includes a fluid port to disperse the fluid.
  • 5. The electrosurgical device of claim 4 wherein the major conductive surface includes the fluid port to disperse the fluid.
  • 6. The electrosurgical device of claim 4 comprising a hypotube having a tube in fluid communication with the fluid port configured to deliver the fluid and a conductive element in electrical communication with the controller and the monopolar electrode configured to deliver the monopolar RF hemostatic sealing signal.
  • 7. The electrosurgical device of claim 6 wherein the tube forms a lumen and the conductive element is disposed within the lumen.
  • 8. The electrosurgical device of claim 6 wherein the conductive element is a wire.
  • 9. The electrosurgical device of claim 6 wherein the hypotube includes an extendable and yieldably collapsible coil segment.
  • 10. The electrosurgical device of claim 1 wherein the electrode assembly extends from the handpiece via a shaft.
  • 11. The electrosurgical device of claim 10 wherein the shaft is generally rigid and of a fixed length.
  • 12. The electrosurgical device of claim 1 wherein the exposed major conductive surface is included in a plurality of exposed major conductive surfaces.
  • 13. The electrosurgical device of claim 12 wherein the plurality of exposed major conductive surfaces are on opposites sides of the electrode assembly.
  • 14. The electrosurgical device of claim 13 wherein the each of the major conductive surfaces include a fluid port to simultaneously deliver the fluid.
  • 15. The electrosurgical device of claim 1 wherein the controller provides a selected order of electrical connections.
  • 16. The electrosurgical device of claim 15 wherein the controller includes a pushbutton to electrically couple the monopolar blade to the monopolar electrode before electrically coupling the monopolar RF hemostatic sealing signal to the monopolar electrode.
  • 17. An electrosurgical device suitable for coupling to an electrosurgical unit, the electrosurgical device comprising: a handpiece having a controller, the controller to receive a monopolar radiofrequency (RF) cutting signal and a monopolar RF hemostatic sealing signal from the electrosurgical unit, the controller having a first setting to provide activation of the monopolar RF cutting signal and a second setting to provide activation of the monopolar RF hemostatic sealing signal in the electrosurgical device; andan electrode assembly extending from the handpiece, the electrode assembly configured to deliver the monopolar RF cutting signal and the monopolar RF hemostatic sealing signal, the electrode assembly comprising, an insulative intermediate component having a major surface and an edge,a monopolar blade disposed on the edge of the intermediate component, the monopolar blade electrically coupled to the controller to receive the monopolar RF cutting signal from the controller, anda monopolar electrode attached to the major surface of the intermediate component, the monopolar electrode electrically coupled to the controller to receive the monopolar RF hemostatic sealing signal from the controller with a dispersed fluid.
  • 18. The electrosurgical device of claim 17 wherein the intermediate component includes a polymer.
  • 19. The electrosurgical device of claim 17 wherein the monopolar blade includes a tapered cutting edge.
  • 20. The electrosurgical device of claim 19 wherein the monopolar blade includes a conductive element partially covered with an electrically insulative coating.
  • 21. The electrosurgical device of claim 20 wherein the electrically insulative coating is glass or ceramic.
  • 22. The electrosurgical device of claim 17 wherein the monopolar electrode includes a fluid port to disperse the fluid.
  • 23. The electrosurgical device of claim 22 comprising a conductive hypotube in fluid communication with the fluid port.
  • 24. The electrosurgical device of claim 23 wherein the conductive hypotube is electrically coupled to the monopolar electrode and configured to deliver the monopolar RF hemostatic sealing signal to the monopolar electrode.
  • 25. The electrosurgical device of claim 24 wherein the conductive hypotube includes a nonconductive wall portion in fluid communication with the fluid port and a conductive element in electrical communication with the monopolar electrode to deliver the monopolar RF hemostatic sealing signal to the monopolar electrode.
  • 26. The electrosurgical device of claim 25 wherein the conductive element is a wire.
  • 27. The electrosurgical device of claim 25 wherein the wall portion forms a lumen and the conductive element is disposed within the lumen.
  • 28. The electrosurgical device of claim 25 wherein the hypotube includes an extendable and yieldably collapsible coil segment.
  • 29. The electrosurgical device of claim 17 wherein the intermediate component electrically isolates the monopolar blade from the monopolar electrode.
  • 30. An electrosurgical device suitable for coupling to an electrosurgical unit, the electrosurgical device comprising: a handpiece having a controller, the controller to receive a monopolar radiofrequency (RF) cutting signal and a monopolar RF hemostatic sealing signal from the electrosurgical unit, the controller to provide activation of the monopolar RF cutting signal and the monopolar RF hemostatic sealing signal in the electrosurgical device;a shaft extending from the handpiece, the shaft including a hypotube configured to deliver a fluid, the hypotube having a conductive element; andan electrode assembly extending from the shaft, comprising: a monopolar blade having a conductive element partially coated with an insulator, the monopolar blade electrically coupled to the controller to receive the monopolar RF cutting signal from the controller; anda monopolar electrode spaced apart and electrically isolated from the monopolar blade, the monopolar electrode having an exposed major conductive surface, the monopolar electrode electrically coupled to the controller via the conductive element to receive the monopolar RF hemostatic sealing signal from the controller with a dispersed fluid via the hypotube.
  • 31. The electrosurgical device of claim 30 wherein the hypotube includes a nonconductive wall portion in fluid communication with a fluid port on the major conductive surface.
  • 32. The electrosurgical device of claim 31 wherein the conductive element is a wire.
  • 33. The electrosurgical device of claim 32 wherein the wall portion forms a lumen and the conductive element is disposed within the lumen.
  • 34. The electrosurgical device of claim 33 wherein the hypotube includes an extendable and yieldably collapsible coil segment.
  • 35. The electrosurgical device of claim 30 wherein the shaft is generally rigid and of a fixed length.
CROSS-REFERENCE TO RELATED APPLICATION

This Non-Provisional Utility Application claims benefit to U.S. Provisional Application No. 62/269,235, filed Dec. 18, 2015, titled “ELECTROSURGICAL DEVICE WITH MONOPOLAR ELECTRODE ASSEMBLY” the entirety of which incorporated herein by reference.

US Referenced Citations (598)
Number Name Date Kind
2888928 Seiger Apr 1957 A
3223088 Barber et al. Dec 1965 A
3682130 Jeffers Aug 1972 A
3750650 Ruttgers Aug 1973 A
3955284 Balson May 1976 A
4014342 Staub et al. Mar 1977 A
4195637 Gruntzig et al. Apr 1980 A
4207897 Loyd et al. Jun 1980 A
4244371 Farin Jan 1981 A
4248224 Jones Feb 1981 A
4275734 Mitchiner Jun 1981 A
4276874 Wolvek et al. Jul 1981 A
4278090 Van Gerven Jul 1981 A
4321931 Hon Mar 1982 A
4342218 Fox Aug 1982 A
4355642 Alfemess Oct 1982 A
4377168 Rzasa et al. Mar 1983 A
4381007 Doss Apr 1983 A
4519389 Gudkin et al. May 1985 A
4598698 Siegmund Jul 1986 A
4601290 Effron et al. Jul 1986 A
4664110 Schanzlin May 1987 A
4671274 Scrochenko Jun 1987 A
4708126 Toda et al. Nov 1987 A
4736749 Lundback Apr 1988 A
4779611 Grooters et al. Oct 1988 A
4802475 Weshahy Feb 1989 A
4878493 Pasternak et al. Nov 1989 A
4919129 Weber et al. Apr 1990 A
4931047 Broadwin et al. Jun 1990 A
4932952 Wojciechowicz, Jr. Jun 1990 A
4943290 Rexroth et al. Jul 1990 A
4950232 Ruzicka et al. Aug 1990 A
4985030 Melzer et al. Jan 1991 A
4998933 Eggers et al. Mar 1991 A
5112299 Pascaloff May 1992 A
5167659 Ohtomo et al. Dec 1992 A
5190541 Abele et al. Mar 1993 A
5195959 Smith Mar 1993 A
5230704 Moberg et al. Jul 1993 A
5234428 Kaufman Aug 1993 A
5254117 Rigby et al. Oct 1993 A
5275609 Pingleton et al. Jan 1994 A
5281215 Midler Jan 1994 A
5309896 Moll et al. May 1994 A
5316000 Chapelon et al. May 1994 A
5317878 Bradshaw et al. Jun 1994 A
5318525 West et al. Jun 1994 A
5322520 Milder Jun 1994 A
5323781 Ideker et al. Jun 1994 A
5324255 Passafaro et al. Jun 1994 A
5324284 Imran Jun 1994 A
5324286 Fowler Jun 1994 A
5330521 Cohen Jul 1994 A
5334181 Rubinsky et al. Aug 1994 A
5334193 Nardella Aug 1994 A
5336220 Ryan et al. Aug 1994 A
5348554 Imran et al. Sep 1994 A
5352222 Rydell et al. Oct 1994 A
5353783 Nakao et al. Oct 1994 A
5354258 Dory Oct 1994 A
5361752 Moll et al. Nov 1994 A
5376078 Dinger et al. Dec 1994 A
5383874 Jackson et al. Jan 1995 A
5385148 Lesh et al. Jan 1995 A
5395312 Desai Mar 1995 A
5396887 Imran Mar 1995 A
5397304 Truckai Mar 1995 A
5400770 Nakao et al. Mar 1995 A
5400783 Pomeranz et al. Mar 1995 A
5401272 Perkins Mar 1995 A
5403309 Coleman et al. Apr 1995 A
5403311 Abele et al. Apr 1995 A
5405348 Anspach et al. Apr 1995 A
5405376 Mulier et al. Apr 1995 A
5409483 Campbell et al. Apr 1995 A
5413556 Whittingham May 1995 A
5417709 Slater May 1995 A
5423807 Mlilder Jun 1995 A
5423811 Imran et al. Jun 1995 A
5427119 Swartz et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431649 Mulier et al. Jul 1995 A
5433708 Nichols et al. Jul 1995 A
5435308 Gallup et al. Jul 1995 A
5437651 Todd et al. Aug 1995 A
5441503 Considine et al. Aug 1995 A
5443463 Stem et al. Aug 1995 A
5443470 Stem et al. Aug 1995 A
5445638 Rydell et al. Aug 1995 A
5450843 Moll et al. Sep 1995 A
5452582 Longsworth Sep 1995 A
5452733 Sterman et al. Sep 1995 A
5460629 Shlain et al. Oct 1995 A
5462545 Wang et al. Oct 1995 A
5465717 Imran et al. Nov 1995 A
5469853 Law et al. Nov 1995 A
5472876 Fahy Dec 1995 A
5478309 Sweezer et al. Dec 1995 A
5478330 Imran et al. Dec 1995 A
5486193 Bourne et al. Jan 1996 A
5487385 Avitall Jan 1996 A
5487757 Truckai et al. Jan 1996 A
5490819 Nicholas et al. Feb 1996 A
5492527 Glowa et al. Feb 1996 A
5496271 Burton et al. Mar 1996 A
5496312 Klicek Mar 1996 A
5497774 Swartz et al. Mar 1996 A
5498248 Milder Mar 1996 A
5500012 Brucker et al. Mar 1996 A
5505500 Webb et al. Apr 1996 A
5505730 Edwards Apr 1996 A
5516505 McDow May 1996 A
5520682 Baust et al. May 1996 A
5522870 Ben-Zion Jun 1996 A
5536267 Edwards et al. Jul 1996 A
5540562 Giter Jul 1996 A
5540708 Lim et al. Jul 1996 A
5542196 Hirsch et al. Aug 1996 A
5542945 Fritzsch Aug 1996 A
5545195 Lennox et al. Aug 1996 A
5545200 West et al. Aug 1996 A
5549661 Kordis et al. Aug 1996 A
5555883 Avitall Sep 1996 A
5556397 Long et al. Sep 1996 A
5558671 Yates Sep 1996 A
5560362 Sliwa, Jr. et al. Oct 1996 A
5560373 DeSantis Oct 1996 A
5562702 Huitema et al. Oct 1996 A
5562720 Stem et al. Oct 1996 A
5569241 Edwards Oct 1996 A
5569243 Kortenbach et al. Oct 1996 A
5569254 Carlson et al. Oct 1996 A
5571088 Lennox et al. Nov 1996 A
5571215 Sterman et al. Nov 1996 A
5573424 Poppe Nov 1996 A
5573532 Chang et al. Nov 1996 A
5575766 Swartz et al. Nov 1996 A
5575788 Baker et al. Nov 1996 A
5575810 Swanson et al. Nov 1996 A
5578007 Imran Nov 1996 A
5582609 Swanson et al. Dec 1996 A
5588432 Crowley Dec 1996 A
5590657 Cain et al. Jan 1997 A
5595183 Swanson et al. Jan 1997 A
5599346 Edwards et al. Feb 1997 A
5605539 Buelna et al. Feb 1997 A
5607462 Imran Mar 1997 A
5609573 Sandock Mar 1997 A
5617854 Munsif Apr 1997 A
5620415 Lucey et al. Apr 1997 A
5620447 Smith et al. Apr 1997 A
5630837 Crowley May 1997 A
5643197 Brucker et al. Jul 1997 A
5647869 Goble et al. Jul 1997 A
5656029 Imran et al. Aug 1997 A
5658278 Imran et al. Aug 1997 A
5637090 McGee et al. Sep 1997 A
5671747 Connor Sep 1997 A
5672153 Lax Sep 1997 A
5673695 McGee et al. Oct 1997 A
5676662 Fleischhacker et al. Oct 1997 A
5676692 Sanghvi et al. Oct 1997 A
5676693 Lafontaine Oct 1997 A
5678550 Bassen et al. Oct 1997 A
5680860 Imran Oct 1997 A
5681278 Igo et al. Oct 1997 A
5681294 Osborne et al. Oct 1997 A
5681308 Edwards et al. Oct 1997 A
5687723 Avitall Nov 1997 A
5687737 Branham et al. Nov 1997 A
5688267 Panescu et al. Nov 1997 A
5690611 Swartz et al. Nov 1997 A
5697536 Eggers et al. Dec 1997 A
5697882 Eggers et al. Dec 1997 A
5697925 Taylor Dec 1997 A
5697927 Imran et al. Dec 1997 A
5697928 Walcott et al. Dec 1997 A
5700262 Acosta Dec 1997 A
5702390 Austin et al. Dec 1997 A
5712543 Sjostrom Jan 1998 A
5713942 Stem Feb 1998 A
5716389 Walinsky et al. Feb 1998 A
5718241 Ben-Haim et al. Feb 1998 A
5718701 Shai et al. Feb 1998 A
5720775 Lanard Feb 1998 A
5722402 Swanson et al. Mar 1998 A
5730074 Peter Mar 1998 A
5730127 Avitall Mar 1998 A
5730704 Avitall Mar 1998 A
5733280 Avitall Mar 1998 A
5735280 Sherman et al. Apr 1998 A
5743903 Stem et al. Apr 1998 A
5755760 Maguire et al. May 1998 A
5766167 Eggers et al. Jun 1998 A
5769846 Edwards et al. Jun 1998 A
5782828 Chen et al. Jul 1998 A
5785706 Bednarek Jul 1998 A
5788636 Curley Aug 1998 A
5792140 Tu et al. Aug 1998 A
5792167 Kablik et al. Aug 1998 A
5797905 Fleischman et al. Aug 1998 A
5797960 Stevens et al. Aug 1998 A
5735290 Nelson et al. Sep 1998 A
5800428 Nelson et al. Sep 1998 A
5800482 Pomeranz et al. Sep 1998 A
5810764 Eggers et al. Sep 1998 A
5810802 Panescu et al. Sep 1998 A
5810809 Rydell Sep 1998 A
5814044 Hooven Sep 1998 A
5827216 Igo et al. Oct 1998 A
5836947 Fleischman et al. Nov 1998 A
5840030 Ferek-Petric et al. Nov 1998 A
5843021 Edwards et al. Dec 1998 A
5843152 Tu et al. Dec 1998 A
5844349 Oakley et al. Dec 1998 A
5846187 Wells et al. Dec 1998 A
5846191 Wells et al. Dec 1998 A
5849023 Mericle Dec 1998 A
5849028 Chen Dec 1998 A
5861021 Thome et al. Jan 1999 A
5871523 Fleischman et al. Feb 1999 A
5871525 Edwards et al. Feb 1999 A
5873845 Cline et al. Feb 1999 A
5873855 Eggers et al. Feb 1999 A
5873886 Larsen et al. Feb 1999 A
5876399 Chia et al. Mar 1999 A
5879295 Li et al. Mar 1999 A
5879296 Ockuly et al. Mar 1999 A
5879348 Owens et al. Mar 1999 A
5881732 Sung et al. Mar 1999 A
5882346 Pomeranz et al. Mar 1999 A
5885278 Fleischman Mar 1999 A
5891142 Eggers et al. Apr 1999 A
5893848 Negus et al. Apr 1999 A
5895355 Schaer Apr 1999 A
5895417 Pomeranz et al. Apr 1999 A
5897553 Mulier Apr 1999 A
5897554 Chia et al. Apr 1999 A
5899898 Arless et al. May 1999 A
5899899 Arless et al. May 1999 A
5899915 Saadat May 1999 A
5902289 Swartz et al. May 1999 A
5904681 West, Jr. May 1999 A
5904711 Flom et al. May 1999 A
5906580 Kline-Schoder et al. May 1999 A
5906587 Zimmon May 1999 A
5906606 Chee et al. May 1999 A
5908029 Knudson et al. Jun 1999 A
5913854 Maguire et al. Jun 1999 A
5916213 Haissaguerre et al. Jun 1999 A
5916214 Cosio et al. Jun 1999 A
5921924 Avitall Jul 1999 A
5921982 Lesh et al. Jul 1999 A
5925045 Reimels et al. Jul 1999 A
5927284 Borst et al. Jul 1999 A
5931810 Grabek Aug 1999 A
5931848 Saadat Aug 1999 A
5935123 Edwards et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5928191 Houser et al. Sep 1999 A
5954661 Greenspon et al. Sep 1999 A
5954686 Garito Sep 1999 A
5975919 Laufer Sep 1999 A
5971980 Sherman Oct 1999 A
5971983 Lesh Oct 1999 A
5980516 Mulier et al. Nov 1999 A
5989248 Tu et al. Nov 1999 A
5993412 Deily et al. Nov 1999 A
5993447 Blewett et al. Nov 1999 A
6004316 Laufer Dec 1999 A
6004319 Goble et al. Dec 1999 A
6007499 Martin et al. Dec 1999 A
6010500 Sherman et al. Jan 2000 A
6012457 Lesh Jan 2000 A
6015391 Rishton et al. Jan 2000 A
6016811 Knopp et al. Jan 2000 A
6018676 Davis et al. Jan 2000 A
6019757 Scheldrup Feb 2000 A
6024733 Eggers et al. Feb 2000 A
6030381 Jones et al. Feb 2000 A
6036687 Laufer et al. Mar 2000 A
6042556 Beach et al. Mar 2000 A
6042593 Storz et al. Mar 2000 A
6048333 Lennox et al. Apr 2000 A
6053923 Veca et al. Apr 2000 A
6056744 Edwards May 2000 A
6056745 Panescu et al. May 2000 A
6056746 Goble May 2000 A
6056747 Saadat et al. May 2000 A
6066139 Ryan et al. May 2000 A
6068653 LaFontaine May 2000 A
6083237 Huitema et al. Jul 2000 A
6086585 Hovda et al. Jul 2000 A
6113596 Hooven et al. Sep 2000 A
6117101 Diederich et al. Sep 2000 A
6120496 Whayne et al. Sep 2000 A
6141576 Littmann et al. Oct 2000 A
6142993 Whayne et al. Nov 2000 A
6142994 Swanson et al. Nov 2000 A
6149620 Baker et al. Nov 2000 A
6152920 Thompson et al. Nov 2000 A
6161543 Cox et al. Dec 2000 A
6165174 Jacobs et al. Dec 2000 A
6190384 Ouchi Feb 2001 B1
6193716 Shannon, Jr. Feb 2001 B1
6210406 Webster Apr 2001 B1
6210410 Farin et al. Apr 2001 B1
6210411 Hofmann et al. Apr 2001 B1
6212426 Swanson Apr 2001 B1
6224592 Eggers et al. May 2001 B1
6231518 Grabek et al. May 2001 B1
6231591 Desai May 2001 B1
6235020 Cheng et al. May 2001 B1
6237605 Vaska et al. May 2001 B1
6238347 Nix et al. May 2001 B1
6238387 Miller, III May 2001 B1
6238393 Mulier May 2001 B1
6245061 Panescu et al. Jun 2001 B1
6245064 Lesh et al. Jun 2001 B1
6245065 Panescu et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6251110 Wampler Jun 2001 B1
6251128 Knopp et al. Jun 2001 B1
6258087 Edwards et al. Jul 2001 B1
6264650 Hovda et al. Jul 2001 B1
6266551 Osadchy et al. Jul 2001 B1
6283988 Laufer et al. Sep 2001 B1
6283989 Laufer et al. Sep 2001 B1
6296638 Davison et al. Oct 2001 B1
6299633 Laufer Oct 2001 B1
6311692 Vaska et al. Nov 2001 B1
6312383 Lizzi et al. Nov 2001 B1
6314962 Vaska et al. Nov 2001 B1
6314963 Vaska et al. Nov 2001 B1
6322559 Daulton et al. Nov 2001 B1
6325797 Stewart et al. Dec 2001 B1
6328735 Curley et al. Dec 2001 B1
6328736 Mulier Dec 2001 B1
6332881 Carner et al. Dec 2001 B1
6352533 Ellman et al. Mar 2002 B1
6358248 Mulier Mar 2002 B1
6361531 Hissong Mar 2002 B1
6364876 Erb et al. Apr 2002 B1
6368275 Sliwa et al. Apr 2002 B1
6371955 Fuimaono et al. Apr 2002 B1
6371956 Wilson et al. Apr 2002 B1
6383151 Diederich et al. May 2002 B1
6385472 Hall et al. May 2002 B1
6398792 O'Connor Jun 2002 B1
6409722 Hoey Jun 2002 B1
6413254 Hissong et al. Jul 2002 B1
6416509 Goble et al. Jul 2002 B1
6425867 Vaezy et al. Jul 2002 B1
6430426 Avitall Aug 2002 B2
6440130 Mulier Aug 2002 B1
6443952 Mulier Sep 2002 B1
6447507 Bednarek et al. Sep 2002 B1
6461314 Pant et al. Oct 2002 B1
6461956 Patterson Oct 2002 B1
6464700 Koblish et al. Oct 2002 B1
6471697 Lesh Oct 2002 B1
6471698 Edwards et al. Oct 2002 B1
6474340 Vaska et al. Nov 2002 B1
6475216 Mulier Nov 2002 B2
6477396 Mest et al. Nov 2002 B1
6478793 Cosman et al. Nov 2002 B1
6484727 Vaska et al. Nov 2002 B1
6488678 Sherman Dec 2002 B2
6488680 Francischelli Dec 2002 B1
6494892 Ireland et al. Dec 2002 B1
6497704 Ein-Gal Dec 2002 B2
6502575 Jacobs et al. Jan 2003 B1
6508815 Strul et al. Jan 2003 B1
6517536 Hooven et al. Feb 2003 B2
6537248 Mulier Mar 2003 B2
6537272 Hoey Mar 2003 B2
6558382 Jahns May 2003 B2
6558385 Bloom et al. May 2003 B1
6575969 Rittman, III et al. Jun 2003 B1
6579288 Swanson et al. Jun 2003 B1
6585732 Mulier Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6603988 Dowlatshahi Aug 2003 B2
6610055 Swanson et al. Aug 2003 B1
6610060 Mulier Aug 2003 B2
6613048 Mulier Sep 2003 B2
6635034 Cosmescu Oct 2003 B1
6645199 Jenkins et al. Nov 2003 B1
6645202 Pless et al. Nov 2003 B1
6648883 Francischelli Nov 2003 B2
6656175 Francischelli Dec 2003 B2
6663627 Francischelli Dec 2003 B2
6666862 Jain et al. Dec 2003 B2
6679882 Komerup Jan 2004 B1
6682501 Nelson Jan 2004 B1
6689131 McClurken Feb 2004 B2
6702810 McClurken et al. Mar 2004 B2
6706038 Francischelli Mar 2004 B2
6706039 Mulier Mar 2004 B2
6716211 Mulier Apr 2004 B2
6716215 David et al. Apr 2004 B1
6736810 Hoey May 2004 B2
6752816 Culp et al. Jun 2004 B2
6755827 Mulier Jun 2004 B2
6764487 Mulier Jul 2004 B2
6766817 da Silva Jul 2004 B2
6775575 Bommannan et al. Aug 2004 B2
6776780 Mulier Aug 2004 B2
6786906 Cobb Sep 2004 B1
6807968 Francischelli Oct 2004 B2
6827713 Bek et al. Dec 2004 B2
6827715 Francischelli Dec 2004 B2
6832996 Woloszko et al. Dec 2004 B2
6849073 Hoey Feb 2005 B2
6858028 Mulier Feb 2005 B2
6887238 Jahns May 2005 B2
6899711 Stewart et al. May 2005 B2
6911019 Mulier Jun 2005 B2
6915806 Pacek et al. Jul 2005 B2
6916318 Francischelli Jul 2005 B2
6918404 Dias da Silva Jul 2005 B2
6936046 Hissong Aug 2005 B2
6942661 Swanson Sep 2005 B2
6949097 Stewart et al. Sep 2005 B2
6949098 Mulier Sep 2005 B2
6953461 Bloom et al. Oct 2005 B2
6960205 Jahns Nov 2005 B2
6962589 Mulier Nov 2005 B2
6979332 Adams Dec 2005 B2
7018241 Caveney et al. Mar 2006 B2
7048687 Reuss et al. May 2006 B1
7066586 da Silva Jun 2006 B2
7156845 Mulier et al. Jan 2007 B2
7166106 Bartel et al. Jan 2007 B2
7179255 Lettice et al. Feb 2007 B2
7207471 Heinrich et al. Apr 2007 B2
7232440 Dumbauld et al. Jun 2007 B2
7237990 Deng Jul 2007 B2
7247155 Hoey et al. Jul 2007 B2
7247161 Johnston et al. Jul 2007 B2
7261711 Mulier et al. Aug 2007 B2
7276074 Adams et al. Oct 2007 B2
7309325 Mulier et al. Dec 2007 B2
7311708 McClurken Dec 2007 B2
7322974 Swoyer et al. Jan 2008 B2
7361175 Suslov Apr 2008 B2
7364579 Mulier et al. Apr 2008 B2
7445436 Mittelstein et al. Nov 2008 B2
7537595 McClurken May 2009 B2
7604635 Bloom et al. Oct 2009 B2
7645277 Bloom et al. Jan 2010 B2
7651494 Bloom et al. Jan 2010 B2
7736361 Palanker et al. Jun 2010 B2
7776014 Visconti et al. Aug 2010 B2
7815634 Bloom et al. Oct 2010 B2
7909820 Lipson et al. Mar 2011 B2
7918852 Tullis et al. Apr 2011 B2
7942872 Ein-Gal May 2011 B2
7976544 McClurken et al. Jul 2011 B2
7993337 Lesh Aug 2011 B2
7997278 Utley et al. Aug 2011 B2
7998140 McClurken Aug 2011 B2
8034071 Scribner et al. Oct 2011 B2
8038670 McClurken Oct 2011 B2
8048070 O'Brien et al. Nov 2011 B2
8083736 Bloom et al. Dec 2011 B2
8109956 Shadeck Feb 2012 B2
8172828 Chang et al. Apr 2012 B2
8177783 Davison et al. May 2012 B2
8202288 Adams et al. Jun 2012 B2
8216233 McClurken et al. Jul 2012 B2
8323276 Palanker et al. Dec 2012 B2
8348946 McClurken et al. Jan 2013 B2
8361068 McClurken Jan 2013 B2
8388642 Munietal Mar 2013 B2
8414572 Davison et al. Apr 2013 B2
8475455 McClurken et al. Jul 2013 B2
8562598 Falkenstein et al. Oct 2013 B2
8568409 O'Brien et al. Oct 2013 B2
8632533 Greeley et al. Jan 2014 B2
8882756 Greeley et al. Nov 2014 B2
8906012 Conley et al. Dec 2014 B2
8920417 Conley et al. Dec 2014 B2
8979842 McNall, III et al. Mar 2015 B2
8992524 Ellman Mar 2015 B1
20010032002 McClurken et al. Oct 2001 A1
20010047183 Privitera et al. Nov 2001 A1
20020038129 Peters et al. Mar 2002 A1
20020049483 Knowlton Apr 2002 A1
20020062131 Gallo, Sr. May 2002 A1
20020082643 Kammerer et al. Jun 2002 A1
20020165541 Whitman Nov 2002 A1
20020198519 Qin et al. Dec 2002 A1
20030014050 Sharkey et al. Jan 2003 A1
20030032954 Carranza et al. Feb 2003 A1
20030045872 Jacobs Mar 2003 A1
20030073993 Ciarrocca Apr 2003 A1
20030097129 Davison et al. May 2003 A1
20030144656 Ocel Jul 2003 A1
20030191462 Jacobs Oct 2003 A1
20030204185 Sherman et al. Oct 2003 A1
20030216724 Jahns Nov 2003 A1
20040015106 Coleman Jan 2004 A1
20040015219 Francischelli Jan 2004 A1
20040024395 Ellman et al. Feb 2004 A1
20040044340 Francischelli Mar 2004 A1
20040049179 Francischelli Mar 2004 A1
20040078069 Francischelli Apr 2004 A1
20040082948 Stewart et al. Apr 2004 A1
20040087940 Jahns May 2004 A1
20040111136 Sharkey et al. Jun 2004 A1
20040111137 Sharkey et al. Jun 2004 A1
20040116923 Desinger Jun 2004 A1
20040138621 Jahns Jul 2004 A1
20040138656 Francischelli Jul 2004 A1
20040143260 Francischelli Jul 2004 A1
20040186465 Francischelli Sep 2004 A1
20040204679 Visconti et al. Oct 2004 A1
20040215183 Hoey Oct 2004 A1
20040220560 Briscoe Nov 2004 A1
20040236322 Mulier Nov 2004 A1
20040243163 Casiano et al. Dec 2004 A1
20040267326 Ocel Dec 2004 A1
20050010095 Stewart et al. Jan 2005 A1
20050037672 Caveney et al. Feb 2005 A1
20050069437 Mittelstein et al. Mar 2005 A1
20050090815 Francischelli Apr 2005 A1
20050090816 McClurken et al. Apr 2005 A1
20050143729 Francischelli Jun 2005 A1
20050171525 Rioux et al. Aug 2005 A1
20050209564 Bonner Sep 2005 A1
20050222566 Nakahira Oct 2005 A1
20050267454 Hissong Dec 2005 A1
20050277970 Norman et al. Dec 2005 A1
20060009756 Francischelli Jan 2006 A1
20060009759 Christian Jan 2006 A1
20060064085 Schechter et al. Mar 2006 A1
20060106375 Werneth et al. May 2006 A1
20060149225 McClurken Jul 2006 A1
20070016185 Tullis et al. Jan 2007 A1
20070049920 Bloom et al. Mar 2007 A1
20070093808 Mulier et al. Apr 2007 A1
20070112343 Mische et al. May 2007 A1
20070118114 Miller et al. May 2007 A1
20070149965 Gallo, Sr. et al. Jun 2007 A1
20070156127 Rioux et al. Jul 2007 A1
20070208332 Mulier et al. Sep 2007 A1
20080004656 Livneh Jan 2008 A1
20080015563 Hoey et al. Jan 2008 A1
20080058796 O'Brien et al. Mar 2008 A1
20080071270 Desinger et al. Mar 2008 A1
20080103494 Rioux et al. May 2008 A1
20080146918 Magnin Jun 2008 A1
20080207208 Schutz Aug 2008 A1
20080234673 Marion Sep 2008 A1
20080262489 Steinke Oct 2008 A1
20090222001 Greeley et al. Sep 2009 A1
20090264879 Bloom et al. Oct 2009 A1
20090270896 Sullivan et al. Oct 2009 A1
20090306655 Stangenes Dec 2009 A1
20100069904 Cunningham Mar 2010 A1
20100100095 Bloom et al. Apr 2010 A1
20100160906 Jarrard Jun 2010 A1
20100168743 Stone et al. Jul 2010 A1
20100204560 Salahieh et al. Aug 2010 A1
20100217255 Greeley et al. Aug 2010 A1
20100241178 Tilson et al. Sep 2010 A1
20100298763 Adams et al. Nov 2010 A1
20110009856 Jorgensen et al. Jan 2011 A1
20110028965 McClurken Feb 2011 A1
20110118772 Chen May 2011 A1
20110137298 Nguyen et al. Jun 2011 A1
20110178515 Bloom et al. Jul 2011 A1
20110190762 Benn et al. Aug 2011 A1
20110196367 Gallo Aug 2011 A1
20110224669 Podany Sep 2011 A1
20110295249 Bloom et al. Dec 2011 A1
20110301578 Muniz-Medina et al. Dec 2011 A1
20110319889 Conley et al. Dec 2011 A1
20120004657 Conley et al. Jan 2012 A1
20120221035 Harvey Feb 2012 A1
20120071712 Manwaring et al. Mar 2012 A1
20120095461 Herscher et al. Apr 2012 A1
20120101496 McClurken et al. Apr 2012 A1
20120116397 Rencher et al. May 2012 A1
20120143293 Mauch et al. Jun 2012 A1
20120151165 Conley et al. Jun 2012 A1
20120157989 Stone et al. Jun 2012 A1
20120184983 Chang et al. Jul 2012 A1
20120191084 Davison Jul 2012 A1
20120191117 Palmer et al. Jul 2012 A1
20120253343 McClurken et al. Oct 2012 A1
20130066310 Manwaring Mar 2013 A1
20130158535 Denis et al. Jun 2013 A1
20130197502 Manwaring et al. Aug 2013 A1
20140188105 Conley et al. Jul 2014 A1
20160317209 Cosmescu Nov 2016 A1
Foreign Referenced Citations (9)
Number Date Country
0 544 274 Nov 1992 EP
62204739 Sep 1987 JP
2009504313 Feb 2009 JP
2008295905 Mar 2015 JP
9637156 Nov 1996 WO
9723169 Jul 1997 WO
9838932 Sep 1998 WO
2007037785 Apr 2007 WO
2010141417 Sep 2010 WO
Non-Patent Literature Citations (4)
Entry
Reexam Cert 4794 For 5,697,536, Jun. 10, 2003, Eggers et al.
International Search Report and Written Opinion dated Nov. 8, 2010 for PCT Appln No. PCT/US2010/048115, filed Sep. 8, 2010, 15 pages.
Partial Translation of Japanese Patent Laid-Open No. S62-204739.
International Search Report and Written Opinion, dated Mar. 30, 2017, PCT App. No. PCT/US2016/067101, filed Dec. 16, 2016, 25 pages.
Related Publications (1)
Number Date Country
20170172646 A1 Jun 2017 US
Provisional Applications (1)
Number Date Country
62269235 Dec 2015 US